Interleukin-18 gene polymorphisms in Korean patients with Behçet's disease

Clinical and Experimental Rheumatology

Volumn 23, Issue 4 SUPPL 38, 2005, Pages

  Jang, Won Cheoul ^a   Park, Sang Bum ^a   Nam, Youn Hyoung ^a   Lee, Shin Seok ^b   Kim, Jong Wan ^a   Chang, In Seong ^a   Kim, Kab Teug ^a   Chang, Hyun Kyu ^a  

^a Dankook University   (South Korea)

^b Chonnam National University Medical School   (South Korea)

Author keywords

Beh et's disease; Interleukin 18; Polymorphism

Indexed keywords

HLA B ANTIGEN; HLA BW51; HLA-BW51; INTERLEUKIN 18;

ADULT; ARTICLE; BEHCET DISEASE; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; HAPLOTYPE; HUMAN; KOREA; MALE; METABOLISM; PATHOLOGY; POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; BEHCET SYNDROME; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HLA-B ANTIGENS; HUMANS; INTERLEUKIN-18; KOREA; MALE; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 33644807434     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. GUL A: BehçeA's disease: an update on the pathogenesis. Clin Exp Rheumatol 2001; 19 (Suppl 24): S6-12.
2. MIZUKI N, OTA M, KATSUYAMA Y et al.: Association analysis between the MIC-A and HLA-B alleles in Japanese patients with Behçet's disease. Arthritis Rheum 1999; 42: 1961-6.
3. VERITY DH, MARR JE, OHNO S, WALLACE GR, STANFORD MR: Behçet's disease, the Silk Road and HLA-B51: Historical and geographical perspectives. Tissue Antigens 1999; 54: 213-20.
4. CHANG HK, KIM JU, CHEON KS, CHUNG HR, LEE KW, LEE IH: HLA-B51 and its allelic types in association with Behçet's disease and recurrent aphthous stomatitis in Korea. Clin Exp Rheumatol 2001; 19 (Suppl 24): S31-5.
5. GUL A, HAJEER AH, WORTHINGTON J, BARRETT JH, OLLIER WE, SILMAN AJ: Evidence for linkage of the HLA-B locus in Behçet's disease, obtained using the transmission disequilibrium test. Arthritis Rheum 2001; 44: 239-40.
6. CHANG HK, JANG WC, PARK SB et al.: Association between interleukin-6 gene polymorphisms and Korean Behçet's disease. Ann Rheum Dis 2005; 64: 339-40.
7. MCINNES IBA GRACIE JA, LEUNG BP, WEI XQ, LIEW FY: Interleukin 18: a pleiotropic participant in chronic inflammation. Immunol Today 2000; 21: 312-5.
8. DINARELLO CA: Interleukin-18. Methods 1999; 19: 121-32.
9. YOSHIMOTO T, TAKEDA K, TANAKA T et al.: IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: Synergism with IL-18 for IFN-gamma production. J Immunol 1998; 161: 3400-7.
10. GRACIE JA, FORSEY RJ, CHAN WL et al.: A proinflammatory role for IL-18 in rheumatoid arthritis. J Clin Invest 1999; 104: 1393-401.
11. PIZARRO TT, MICHIE MH, BENTZ M et al.: IL-18, a novel immunoregulatory cytokine, is up-regulated in Crohn's disease: Expression and localization in intestinal mucosal cells. J Immunol 1999; 162: 6829-35.
12. BALASHOV KE, ROTTMAN JB, WEINER HL, HANCOCK WW: CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions. Proc Natl Acad Sci USA 1999; 96: 6873-8.
13. GIEDRAITIS V, HE B, HUANG WX, HILLERT J: Cloning and mutation analysis of the human IL-18 promoter: A possible role of polymorphisms in expression regulation. J Neuroimmunol 2001; 112: 146-52.
14. KRETOWSKI A, MIRONCZUK K, KARPINSKA A et al.: Interleukin-18 promoter polymorphisms in type 1 diabetes. Diabetes 2002; 51: 3347-9.
15. IDE A, KAWASAKI E, ABIRU N et al.: Association between IL-18 gene promoter polymorphisms and CTLA-4 gene 49A/G polymorphism in Japanese patients with type 1 diabetes. J Autoimmun 2004; 22: 73-8.
16. TAKADA T, SUZUKI E, MOROHASHI K, GEJYO F: Association of single nucleotide polymorphisms in the IL-18 gene with sarcoidosis in a Japanese population. Tissue Antigens 2002; 60: 36-42.
17. HENINGER E, TRESZL A, KOCSIS I, DERFALVI B, TULASSAY T, VASARHELYI B: Genetic variants of the interleukin-18 promoter region (-607) influence the course of necrotising enterocolitis in very low birth weight neonates. Eur J Pediatr 2002; 161: 410-1.
18. HAMZAOUI A, GHRAIRI H, AMMAR J, ZEKRI S, GUEMIRA F, HAMZAOUI K: IL-18 mRNA expression and IFN-gamma induction in bronchoalveolar lavage from Behçet's disease. Clin Exp Rheumatol 2003; 21 (Suppl 30): S8-14.
19. HAMZAOUI K, HAMZAOUI A, GUEMIRA F, BESSIOUD M, HAMZA M, AYED K: Cytokine profile in Behçet's disease patients. Relationship with disease activity. Scand J Rheumatol 2002; 31: 205-10.
20. INTERNATIONAL STUDY GROUP FOR BEHÇET'S DISEASE: Criteria for diagnosis of Behçet's disease. Lancet 1990; 335: 1078-80.
21. CHANG HK, CHEON KS: The clinical significance of a pathergy reaction in patients with Behçet's disease. J Korean Med Sci 2002; 17: 371-4.
22. KIM JU, CHANG HK, LEE SS et al.: Endothelial nitric oxide synthase gene polymorphisms in Behçet's disease and rheumatic diseases with vasculitis. Ann Rheum Dis 2003; 62: 1083-7.
23. WALSH PS, METZGER DA, HIGUCHI R: Chelex® 100 as a medium for simple extraction of DNA for PCR-based typing from forensic material. Biotechniques 1991; 10: 506-13.
24. ZHAO JH, CURTIS D, SHAM PC: Model-free analysis and permutation tests for allelic associations. Hum Hered 2000; 50: 133-9.
25. ZAPATA C, CAROLLO C, RODRIGUEZ S: Sampling variance and distribution of the D' measure of overall gametic disequlibrium between multiallelic loci. Ann Hum Genet 2001; 65: 395-406.
26. TERWILLIGER J, OTT J: Handbook for Human Genetic Linkage. Baltimore, Johns Hopkins University Press, 1994: 188-98.
27. GUL A, INANC M, OCAL L, ARAL O, KONICE M: Familial aggregation of Behçet's disease in Turkey. Ann Rheum Dis 2000; 59: 622-5.
28. AHMAD T, WALLACE GR, JAMES T et al.: Mapping the HLA association in Behçet's disease: A role for tumor necrosis factor polymorphisms? Arthritis Rheum 2003; 48: 807-13.
29. FRASSANITO MA, DAMMACCO R, CAFFORIO P, DAMMACCO F: Th1 polarization of the immune response in Behçet's disease: A putative pathogenetic role of interleukin-12. Arthritis Rheum 1999; 42: 1967-74.
30. SUGI-IKAI N, NAKAZAWA M, NAKAMURA S, OHNO S, MINAMI M: Increased frequencies of interleukin-2- and interferon-gamma-producing T cells in patients with active Behçet's disease. Invest Ophthalmol Vis Sci 1998; 39: 996-1004.
31. TONE M, THOMPSON SA, TONE Y, FAIRCHILD PJ, WALDMANN H: Regulation of IL-18 (IFN-gamma-inducing factor) gene expression. J Immunol 1997; 159: 6156-63.
32. SIVALINGAM SP, YOON KH, KOH DR, FONG KY: Single-nucleotide polymorphisms of the interleukin-18 gene promoter region in rheumatoid arthritis patients: Protective effect of AA genotype. Tissue Antigens 2003; 62: 498-504.